Galapagos NV ADR (GLPG)

$54.25 0.08 (0.15%)

16:00 EDT GLPG Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jan 27, 2022

Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 100,766

Day's Range $54.20 - $54.86

52-Week Range $46.41 - $72.11

Dividend & Yield N/A (N/A)

GLPG Stock Predictions, Articles, and Galapagos NV ADR News

From InvestorPlace
From the Web

7 Beautiful Biotech Stocks to Buy Here

By Louis Navellier and the InvestorPlace Research Staff Apr 24, 2020

Covid-19 has put the biotech stocks in the spotlight, but treatments for the pandemic are far from the only reason investors should watch this space.

5 Biotech Stocks to Buy for a Strong Growth Prognosis

By Aaron Levitt, InvestorPlace Contributor Mar 11, 2020

The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.

7 Stocks to Buy Over $100 That Are Worth Their Price Tags

By Louis Navellier, Editor, Growth Investor Feb 24, 2020

Not all high-priced stocks have earned their valuations. But these seven stocks to buy are great despite their price tags.

7 Top-Rated Stocks to Buy for a More Powerful Portfolio

By Louis Navellier, Editor, Growth Investor Jan 21, 2020

The market is hot, but that’s no reason to forgo quality when picking the top stocks to buy now. Here are seven that stand out from the rest.

7 Exciting Biotech Stocks to Buy Now

By Louis Navellier, Editor, Growth Investor Dec 2, 2019

Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.

Nasdaq Today: Bitcoin & Libra; What’s Broadcom Doing?

By Bret Kenwell, InvestorPlace Contributor Jul 15, 2019

It was quiet for the Nasdaq today, but bitcoin, Facebook's Libra and the Broadcom-Symantec deal were in focus.

Galapagos Deal: GLPG Stock Rockets Higher on Gilead Stake

By William White, InvestorPlace Writer Jul 15, 2019

A Galapagos deal with Gilead that includes a collaboration and an investment in the company has GLPG stock heading higher on Monday.

5 Clinical-Stage Biotech Stocks to Buy

By Aaron Levitt, InvestorPlace Contributor Feb 25, 2019

There are plenty of potential in clinical-stage biotech stocks. Here are five with some wonderful catalysts.

5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage

By Aaron Levitt, InvestorPlace Contributor Oct 17, 2018

After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.

Biggest Movers in Manufacturing Stocks Now – BSPM RTTR SCL CCXI

By Portfolio Grader Oct 18, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Gilead Sciences, Inc. Is More Than an HCV Play (GILD)

By James Brumley, InvestorPlace Feature Writer Oct 12, 2016

Gilead Sciences (GILD) stock is a bargain at these prices. Traders just have yet to see the glass as half full.

Galapagos (GLPG) Gets a Buy Rating from Morgan Stanley

From TipRanks Jul 15, 2022

Morgan Stanley analyst Matthew Harr...

Galapagos In-licenses Inflammatory Bowel Disease Drug Targets From Scipher Medicine

From Benzinga May 24, 2022

RBC Expects Business Development To Unlock This Pharma Stock's Balance Sheet Value

From Benzinga May 9, 2022

RBC Capital Markets views Galapagos' NV (NASDAQ: GLPG) Q1 Jyseleca revenues in line as the story focuses on whether new leadership can unlock value from GLPG's ample balance sheet.

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study

From Benzinga May 5, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios

From Benzinga Feb 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...

Galapagos (GLPG) Receives a Hold from RBC Capital

From TipRanks Jan 7, 2022

RBC Capital analyst Brian Abrahams

TELECOM TRIUMPH?

Galapagos NV ADR (GLPG)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

TELECOM TRIUMPH?

Galapagos NV ADR (GLPG)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GLPG Stock Predictions, Articles, and Galapagos NV ADR News

Subscriber Sign in